Allen

Biography

Dr. Cato has more than nineteen years of experience in the development of new drugs in the pharmaceutical industry, with particular expertise in the areas of drug metabolism and pharmacokinetics. Prior to joining Cato Research early in 2000, Dr. Cato was employed as a clinical pharmacokineticist for more than two years at Ligand Pharmaceuticals, and for four years at Abbott Laboratories. While in pharmacy school, Dr. Cato spent a year at Burroughs Wellcome where he worked as a member of the data management team on the development of Zidovudine. Dr. Cato has been involved in the conduct and analysis of both nonclinical and clinical drug disposition studies, and has been responsible for coordination of the development and validation of several bioanalytical methods. He has experience with both small molecules and large oligonucleotides and has contributed to the Human Pharmacokinetics Sections of seven NDAs. Dr. Cato has more than nineteen years of experience in the development of new drugs in the pharmaceutical industry, with particular expertise in the areas of drug metabolism and pharmacokinetics. Prior to joining Cato Research early in 2000, Dr. Cato was employed as a clinical pharmacokineticist for more than two years at Ligand Pharmaceuticals, and for four years at Abbott Laboratories. While in pharmacy school, Dr. Cato spent a year at Burroughs Wellcome where he worked as a member of the data management team on the development of Zidovudine. Dr. Cato has been involved in the conduct and analysis of both nonclinical and clinical drug disposition studies, and has been responsible for coordination of the development and validation of several bioanalytical methods. He has experience with both small molecules and large oligonucleotides and has contributed to the Human Pharmacokinetics Sections of seven NDAs.

Research Interest

Pharmacokinetics